Robin Marcus

Head of Global Decentralized Trials Market Development, Marken

Robin Marcus is Marken’s Head of Global Decentralized Trials Market Development and has over 30 years of experience driving business optimization and championing innovation. She has successfully launched new products, divisions and companies, exceeding corporate goals and building collaborative, high-performance teams to deliver results across the healthcare enterprise. For the past 10 years, Robin has focused on the global expansion of decentralized clinical trial (DCT) services, including mobile clinical services, e-consent, eCOA/ePRO, telemedicine and ambulatory devices. Robin’s clinical background and experience working in the pharma and biotech industries is critical in assessing and developing DCT strategies. Prior to joining Marken, Robin was the Chief Strategy Officer at GlobalCare Clinical Trials and Executive Director of DCT Implementation for an acquisition by LabCorp Drug Development.  

Talk to Robin about these topics and more: 

• Optimizing and deploying patient-centric DCT services
• Enhancing investigator site operations and reducing site burden
• Ensuring high-quality biological sample collection and transport
• Clinical research options for patient recruitment, adherence and retention
• Strategies for addressing study challenges and recovering momentum